Set the goal. RevWorx builds the roadmap, ranks the targets, and drives execution to signed contract, built for commercial and market access teams at medical device, diagnostics, pharmaceutical, health technology, and medical equipment companies.
No spreadsheets. No gut-feel targeting. No generic CRM tasks.


Your 24-hour co-worker. It keeps your launch organized and helps you reach your goals.
A new customer connects Outlook, Calendar and Drive. The assistant reads the board deck, pipeline tracker and site-visit notes, pulls its own market context, asks three questions, then drafts the plan.
The questions commercial leaders and reps actually ask, each answered by a working part of the platform. Not a black box: every ranking and recommendation shows visible reasoning.

"What does the path to this commercial goal actually look like?"
Define the offering, procedure, and target market. RevWorx checks what you already have, then builds the roadmap from goal to signed contract.

"Which facilities are worth pursuing first, and what's the evidence?"
Adoption Readiness, Clinical Fit, and Procedure Momentum combine into one ranked list, with the reasoning behind every score always visible.

"Who actually drives the adoption decision at each account?"
KOL signals, coauthorship, and disclosure data surface who actually drives the adoption decision at each account.

"Where is the incumbent weak, and why is this account timely now?"
See incumbent position and the specific trigger that makes an account timely now, not just generically attractive.
"Will this indication get paid for, in this account's region?"
Payer and coverage position surfaced at the account level, not a separate lookup in a different tool.

"What does a rep do on day one, and how is progress tracked?"
Every account gets a specific next action with content prepped, then moves through a visible stage funnel so stalls and outcomes stay in view.
See how execution worksKnowing who to target is half the job. RevWorx carries every account from target to signed contract, and the same engine already runs across spine, wound care, diagnostics, neuro, cardio, orthopedics, and robotic microsurgery — procedural, diagnostic, and consumable categories alike.
The Playbook Engine turns a score into a specific next action, re-engage the clinical champion, prep for a first case, escalate a stalled account, never a generic "follow up" reminder.
Meeting briefs, talking points, follow-up emails, and clinical evidence summaries are generated automatically, reasoning shown, so reps walk in prepared.
Every account moves through a visible stage funnel with a full audit trail of what was recommended, what was done, and what moved the needle.
Stalled accounts and missed follow-ups surface on their own, escalating to leadership when a human needs to step in.

Procedure volume rose 18% last quarter and the incumbent contract renews in 90 days. Meeting brief and evidence summary are drafted and ready to send.
Every number on screen carries a label, so what's proven is never confused with what's estimated.
Commercial leaders get org-wide visibility into what's on track, at risk, or stalled, with escalation surfaced automatically. Territory managers and reps get a daily ranked queue with meeting prep and outreach drafted for them.



RevWorx is built and run by Alok Gangaramany. Before founding RevWorx, he spent 13+ years at Final Mile Consulting (part of Fractal Analytics), working on behavior-change and AI product initiatives across financial services, healthcare, and infrastructure, plus earlier enterprise systems work at Capgemini.
Across those healthcare engagements, the pattern kept repeating: strong products with a real ability to improve health outcomes, stalling out commercially because no one figured out where adoption was actually likely and how to drive it. RevWorx is the product of that experience: a founder-led company built to solve a problem he's seen up close.
Schedule a short walkthrough. We'll show you what a ranked target list and a recommended play look like for your own territory.